Gleamer BoneView

🟢Active

BoneView is Gleamer’s AI-based radiography software for detecting and localizing fractures, joint effusions, dislocations, and bone lesions on X-rays, providing visual annotations to assist clinicians.

Why Abandoned

Gleamer currently lists BoneView on its official website, and FDA records include a cleared BoneView device. Current product materials indicate ongoing commercial availability.

🩺 Health Signals

No checks have been run on this tool yet.

📅 Timeline

2017-01-01

Gleamer founded

2022-03-22

BoneView receives FDA clearance

2023-06-28

Gleamer raises €27 million

2024-06-26

Gleamer acquires Caerus Medical

🔄 Alternatives to Gleamer BoneView

🪦 Other dead Healthcare tools

Frequently Asked Questions

What is Gleamer BoneView?

Gleamer BoneView is AI-based medical software that analyzes standard radiographs and highlights suspected musculoskeletal abnormalities to support clinician interpretation.

What can BoneView detect on X-rays?

According to Gleamer, BoneView can flag and localize findings including fractures, joint effusions, dislocations, and bone lesions. Available indications can vary by market and regulatory authorization.

Is Gleamer BoneView FDA cleared?

Yes. The FDA 510(k) database lists BoneView as cleared radiological computer-assisted detection software. Users should verify the authorized indications and current labeling for their jurisdiction.

Does BoneView replace a radiologist or physician?

No. BoneView is designed as clinical decision-support software. Findings must be reviewed in context by qualified healthcare professionals and should not replace independent clinical judgment.

Who makes Gleamer BoneView?

BoneView is developed by Gleamer, a Paris-based medical-imaging AI company founded in 2017 by Christian Allouche, Rob Grist, and Alexandre Salvador.